TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
VCRE

Vicore Pharma Holding AB

Healthcare · Biotechnology

9.00$ -3.5% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow VCRE
Line item 2022 2023 2024 2025
– – -150.8% -9,843.8%
– – 2.1% 0.0%
– – -1.7% 1,069.2%
– – 0.0% 0.0%
– – 748.2% -14,296.5%
– – -150.8% -9,843.8%

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?